Which has the lower trailing P/E, BIIB or IQV?

IQV has the lower trailing P/E: BIIB trades at 38.92 and IQV at 32.04. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, BIIB or IQV?

Over the past five years, IQV grew revenue faster — BIIB at a -3.19% CAGR versus IQV at 5.61%.

Is BIIB or IQV more profitable?

BIIB runs the higher net margin — BIIB at 8.39% versus IQV at 8.10%.

How have BIIB and IQV total returns compared?

Over the past 10 years, BIIB delivered -3.47% and IQV delivered 12.28% annualized total return. Past performance doesn't predict future results.

Biogen Inc. (BIIB) vs IQVIA Holdings Inc. (IQV)

A side-by-side comparison of Biogen Inc. and IQVIA Holdings Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 4, 2026. Differences are shown without an overall score or investment verdict.

BIIB

Biogen Inc.

$32.49B

$219.88HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

IQV

IQVIA Holdings Inc.

$42.50B

$258.21HealthcareDelayed quote: Oct 2, 2026, 4:00 PM EDT

Total return — BIIB vs IQV

growth of $100 · dividends reinvested · last 10y

BIIB -28.1% (-3.2%/yr)IQV +225.7% (+12.5%/yr)IQV compounded faster over this window

BIIB IQV

BIIB vs IQV: by the numbers

•IQV is the larger company ($42.50B vs $32.49B market cap).
•IQV trades at the lower trailing earnings multiple (32.04 vs 38.92 P/E), one valuation lens rather than an overall verdict.
•BIIB converts more revenue to profit (8.39% vs 8.10% net margin).
•IQV grew revenue faster over the past five years (5.61% vs -3.19% CAGR).

Metrics side by side

Valuation

Metric	BIIB	IQV
P/E ratio	38.92	32.04
Forward P/E	17.71	19.91
PEG ratio	N/A	0.79
P/S ratio	3.27	2.50
P/B ratio	1.72	6.89
EV / EBITDA	N/A	16.29
FCF yield	8.30%	5.14%

Profitability

Metric	BIIB	IQV
Gross margin	67.71%	26.23%
Operating margin	12.79%	13.57%
Net margin	8.39%	8.10%
ROE	4.43%	22.28%
ROIC	4.28%	8.32%

Growth (annualized)

Metric	BIIB	IQV
Revenue CAGR (5Y)	-3.19%	5.61%
EPS CAGR (5Y)	-18.67%	40.21%
FCF CAGR (5Y)	-11.63%	0.76%
Total return CAGR (5Y)	-4.98%	1.34%

Some values include inputs from SEC filing.

Frequently asked

Which has the lower trailing P/E, BIIB or IQV?: IQV has the lower trailing P/E: BIIB trades at 38.92 and IQV at 32.04. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, BIIB or IQV?: Over the past five years, IQV grew revenue faster — BIIB at a -3.19% CAGR versus IQV at 5.61%.
Is BIIB or IQV more profitable?: BIIB runs the higher net margin — BIIB at 8.39% versus IQV at 8.10%.
How have BIIB and IQV total returns compared?: Over the past 10 years, BIIB delivered -3.47% and IQV delivered 12.28% annualized total return. Past performance doesn't predict future results.

Go deeper

Full BIIB analysis Full IQV analysis Interactive comparison tool

Dig into the metrics

Biogen P/E ratio IQVIA P/E ratio Biogen ROE IQVIA ROE Biogen operating margin IQVIA operating margin Biogen revenue growth IQVIA revenue growth Biogen free cash flow IQVIA free cash flow

Biogen & IQVIA appear in these rankings

Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 4, 2026.